Skip to main content

Noel Christian's Form 4 filing

Cryomass Technologies, Inc. (CRYM) · filed Nov 12, 2021

Accession no.
0001213900-21-058624
Filed
Nov 12, 2021, 3:35 PM ET
Trade date
Nov 11, 2021
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market purchases total $202.0K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Noel ChristianCIK 0001856925Director, Officer (Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 11, 2021Common StockPPurchaseAcquired+250,000$0.20+$50,0006,250,000Direct
Nov 11, 2021Common StockPPurchaseAcquired+760,000$0.20+$152,0007,010,000Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 11, 2021Common StockPPurchaseAcquired+250,000–F2–250,000Direct
Nov 11, 2021Common StockPPurchaseAcquired+760,000–F2–1,010,000Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The purchase reflects a Unit purchase, each Unit consisting of (a) 10,000 shares of common stock at a price of $0.20 per share and (b) one common stock purchase warrant exercisable to purchase 10,000 additional shares of common stock of the corporation (each such additional share a "Warrant Share") at an exercise price of $0.40 per Warrant Share. For the purposes of this report no purchase price has been attributed to the warrant.

Referenced by the price of 2 transactions in Table II.

Read the full filing on SEC EDGAR (opens in a new tab)